Insulin and GHRP-6 had differential beneficial effects on pituitary cell turnover in diabetic rats: insulin through anti-apoptosis, GHRP-6 through proliferation — different mechanisms for restoring pituitary health.
Key findingInsulin and GHRP-6 had differential beneficial effects on pituitary cell turnover in diabetic rats: insulin through anti-apoptosis, GHRP-6 through pro
What the researchers found
Insulin and GHRP-6 had differential beneficial effects on pituitary cell turnover in diabetic rats: insulin through anti-apoptosis, GHRP-6 through proliferation — different mechanisms for restoring pituitary health.
Why it matters
Relevant for peptide research.
How the study worked
research study.
What this study cannot tell us
See abstract.
How to read the evidence
emerging evidence.
When this study was published
Published in 2011.
The bigger picture
Advances peptide research.
Questions still open
- Further research needed.
Common questions
What was studied?
What was found?
Read the original research
Insulin and growth hormone-releasing peptide-6 (GHRP-6) have differential beneficial effects on cell turnover in the pituitary, hypothalamus and cerebellum of streptozotocin (STZ)-induced diabetic rats.
Molecular and cellular endocrinology, 337(1-2), 101-13
Citation
Granado, Miriam; García-Cáceres, Cristina; Tuda, María; Frago, Laura M; Chowen, Julie A; Argente, Jesús. (2011). Insulin and growth hormone-releasing peptide-6 (GHRP-6) have differential beneficial effects on cell turnover in the pituitary, hypothalamus and cerebellum of streptozotocin (STZ)-induced diabetic rats.. Molecular and cellular endocrinology, 337(1-2), 101-13. https://doi.org/10.1016/j.mce.2011.02.002